Sitemap

Nebojša Škuljec, Director, Merck Sharp & Dohme

Always In The Service Of Patients

Merck Sharp & Dohme will continue to serve patients and the health system in Serbia, and the key to realising success will be regular communication and exchange of information with state institutions, health policymakers, health workers and patients.

We will invest significant resources in the discovery, development, production and global distribution of the Covid-19 vaccine, in order for it to be available to the population around the world as soon as possible, and we will develop an antiviral drug for severe coronavirus forms, in cooperation with Ridgeback Biotherapeutics LP, announces Merck Sharp & Dohme Director Nebojša Škuljec, speaking in this interview for CorD.

The new Coronavirus pandemic is continuing and keeping the world in a state of emergency. Is this a challenge for pharmaceutical companies like yours?

The appearance of Covid-19 has had a major impact on the whole world and I think that the health and pharmaceutical sector will no longer be the same after the end of the pandemic. 

Merck Sharp Dohme logo

Globally, our company responded quickly by increasing its production of medicines, and we in Serbia have ensured that sufficient quantities of all medicines are available to patients infected with Covid-19, as well as to those needing therapy for chronic diseases.

In addition to this, in accordance with our long tradition of corporate social responsibility in Serbia, we have responded with other forms of assistance worth 100,000 euros.

Serbia has long since lagged behind Europe when it comes to the introduction of innovative therapies. Is that situation slowly improving?

In terms of the availability of innovative therapies, Serbia lagged behind significantly in the period from 2012 to 2016. The National Health Insurance Fund and the Ministry of Health have exerted significant efforts in the last few years in order to achieve improvement in this segment, given the unequivocal value of modern therapies, in terms of ensuring a longer, healthier and more productive life for patients, as well as in terms of reducing the number of hospitalisations, complications and co-morbidities.

MSD Serbia remains committed to its goal of preserving and improving human health, both globally and in our country

At the end of 2019, the Ministry of Finance approved an additional investment worth five billion dinars, which resulted in the introduction of modern therapies, as early as the beginning of this year, for the treatment of lung cancer, among other things.

What is the future of the pharmaceutical industry? Biological medicines; personalised therapies?

The focus of the pharmaceutical industry has shifted from medicines to the patient, which we can certainly call personalised medicine. At MSD Serbia we imply that this means that every patient should have the opportunity to get the right therapy at the right time, which will provide the best treatment outcomes and/or the prevention of later illness.

MSD was the first company to come up with the immunotherapy that revolutionised the treatment of advanced malignant diseases. For now it is used in the treatment of malignant melanomas and lung cancer, and it is already available around the world or is being tested for a larger number of types of cancer. We hope that, with the widespread use of immunotherapy as a new standard of treatment in oncology, cancers will increasingly become chronic and not fatal diseases.

With what plans and ambitions are you awaiting the year ahead, during which you will mark a quarter of a century of your business in Serbia?

The time ahead of us will bring a lot of new challenges. We believe that greater investment in prevention and treatment will have a positive impact on all infectious diseases that represent a threat to the sustainability of health systems and society as a whole. And here too we have much more to offer, from vaccines to prevent infections caused by HPV, through the latest antibiotics, to effective therapies for HIV infections and hepatitis.

More...

Dejan Aleksov, Director at BENU Pharmacies

We Know What You Need

BENU is part of German company Phoenix, which has in its composition more than 2,400 pharmacies in 14 European countries. BENU has managed to...

Vladimir Vasojević, Belchim Crop protection SRB

Food Quality & Safety Without Compromise

Belchim is a European company that has a knowledge base from the most agriculturally developed countries in Europe, such as Belgium, the Netherlands, France,...

Boban Janković, President of the Municipality of Mionica

Boldly Moving Forward

Thanks to investments in infrastructure according to plans, the modernisation of devastated old industrial zones and, primarily, the opening of Miloš the Great Highway...

Vladimir Stojanović, President of the Municipality of Kučevo

We’re Reopening Factories

In the past period, The Municipality of Kučevo launched a series of activities in previous period in order to create a favourable business environment...

News

Italy Sends Serbia The Medical Team To Help Fight COVID19

The Italian Embassy in Belgrade announces that a six-member medical team has arrived in Serbia: two anesthesiologists, one emergency...

Farewell Visit Of The Ambassador Of Israel To Serbia

Prime Minister Ana Brnabic met with Ambassador of Israel to Serbia Alona Fisher Kamm and on that occasion pointed...

Air Serbia Introduces New Measures Due To Coronavirus

Due to the coronavirus pandemic, Air Serbia re-introduced flight bans and travel restrictions and is forced to further adjust...

Montenegro Building Hydroelectric Power Plant Without Asking Serbia For Permission

The state of Montenegro, judging by the 2020 Concession Plan for the use of watercourses to develop hydroelectric power...

Binding Verdict In Favour Of ABC Serbia

After a process lasting eight years, the High Commercial Court of the Republic of Croatia has brought a binding...

Italy Sends Serbia The Medical Team To Help Fight COVID19

The Italian Embassy in Belgrade announces that a six-member medical team has arrived in Serbia: two anesthesiologists, one emergency...

Farewell Visit Of The Ambassador Of Israel To Serbia

Prime Minister Ana Brnabic met with Ambassador of Israel to Serbia Alona Fisher Kamm and on that occasion pointed...

Air Serbia Introduces New Measures Due To Coronavirus

Due to the coronavirus pandemic, Air Serbia re-introduced flight bans and travel restrictions and is forced to further adjust...

Binding Verdict In Favour Of ABC Serbia

After a process lasting eight years, the High Commercial Court of the Republic of Croatia has brought a binding...

EU Donates €16m For Water Transport Projects

The European Commission approved non-repayable funds in the amount of €16 million for financing projects in the field of...